Fig. 4From: Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorderExploratory analysis of ABC-Core in participants with less severe symptoms at baseline (ADOS 6–7) treated with 10 mg/kg or placeboBack to article page